Clinical significance of platelet count at day +60 after allogeneic peripheral blood stem cell transplantation

Journal of Korean Medical Science

Volumn 21, Issue 1, 2006, Pages 46-51

  Kim, Dong Hwan ^a   Sohn, Sang Kyun ^a   Baek, Jin Ho ^a   Kim, Jong Gwang ^a   Lee, Nan Young ^a   Won II, Dong ^a   Suh, Jang Soo ^a   Lee, Kyu Bo ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Allogeneic; Mortality; Opportunistic Infections; Peripheral Blood Stem Cell Transplantation; Thrombocytopenia; Transplantation, homologous

Indexed keywords

EID: 33144459847     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.1.46     Document Type: Article

References (14)

1. First LR, Smith BR, Lipton J, Nathan DG, Parkman R, Rappeport JM. Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic, thrombocytopenic syndromes. Blood 1985; 65: 368-74.
2. Nash RA, Gooley T, Davis C, Appelbaum FR. The problem of throm bocytopenia after hematopoietic stem cell transplantation. Oncologist 1996; 1: 371-80.
3. Akpek G, Lee S J, Flowers ME, Pavletic SZ, Arora M, Lee S, Piantadosi S, Guthrie KA, Lynch JC, Takatu A, Horowitz MM, Antin JH, Weisdorf DJ, Martin PJ, Vogelsang GB. Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 2003; 102: 802-9.
4. Akpek G, Zahurak ML, Piantadosi S, Margolis J, Doherty J, Davidson R, Vogelsang GB. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001; 97: 1219-26.
5. Sullivan KM, Witherspoon RP, Storb R, Deeg HJ, Dahlberg S, Sanders JE, Appelbaum FR, Doney KC, Weiden P, Anasetti C, Loughran TP, Hill R, Shields A, Yee G, Shulman H, Nims J, Strom S, Thomas ED. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. Blood 1988; 72: 555-61.
6. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-76.
7. Bolwell B, Pohlman B, Sobecks R, Andresen S, Brown S, Rybicki L, Wentling V, Kalaycio M. Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant 2004; 33: 419-23.
8. Sohn SK, Kim JG, Seo KW, Chae YS, Jung JT, Suh JS, Lee KB. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2002; 30: 81-6.
9. Sohn SK, Kim JG, Sung WJ, Kim DH, Suh JS, Lee KS, Lee KB. Harvesting peripheral blood stem cells from healthy donors on 4th day of cytokine mobilization. J Clin Apheresis 2003; 18: 186-9.
10. Sohn SK, Kim JG, Chae YS, Kim DH, Lee NY, Suh JS, Lee KB. Large-volume leukapheresis using femoral venous access for harvesting peripheral blood stem cells with the Fenwal CS 3000 Plus from normal healthy donors: predictors of CD34+ cell yield and collection efficiency. J Clin Apheresis 2003; 18: 10-5.
11. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-8.
12. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-17.
13. Anasetti C, Rybka W, Sullivan KM, Banaji M, Slichter SJ. Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood 1989; 73: 1054-8.
14. Przepiorka D, Anderlini P, Saliba R, Cleary K, Mehra R, Khouri I, Huh YO, Giralt S, Braunschweig I, van Besien K, Champlin R. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 2001; 98: 1695-700.